# Pyxis Oncology, Inc.: Form 8-K, filed Aug 4, 2025

- Company: [Pyxis Oncology, Inc.](/companies/pyxs.md) (CIK 1782223)
- Form: 8-K
- Filed: 2025-08-04
- Accepted by EDGAR: Aug 4, 2025, 07:26 ET
- Period: 2025-08-04
- Accession: 0000950170-25-101618
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1782223/000095017025101618/pyxs-20250804.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1782223/000095017025101618/

## Items reported

- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1782223/000095017025101618/pyxs-20250804.htm

Filed Aug 4, 2025.
Source: SEC EDGAR, the filing index for accession 0000950170-25-101618. Last ingested by Listed: Nov 5, 2026, 12:09 ET. No prices; not investment advice.